USFDA

USFDA concludes GMP inspection at Dr Reddy’s R&D centre

Read more

Eugia Steriles receives EIR from US FDA

Read more

Strides Pharma subsidiary receives USFDA approval for 60 mg Fluoxetine tablets

Read more

Sun Pharma and Moebius Medical gain fast track designation for MM-II for the treatment of Osteoarthritis Knee Pain

Read more

Strides gains USFDA approval for Theophylline Extended-Release Tablets, 300 mg and 450 mg

Read more

Dr Reddy’s receives EIR for API manufacturing facility

Read more

Alembic gains final USFDA approval for Albendazole Tablets USP, 200 mg

Read more

Lupin launches Mirabegron Extended-Release Tablets in the US

Read more

Zydus gains final USFDA approval for Amantadine extended-release capsules 68.5 mg and tentative approval for 137 mg

Read more

Zydus receives USFDA warning letter for Jarod facility

Read more